Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1978 1
1999 1
2006 1
2013 2
2014 3
2015 1
2016 11
2017 14
2018 38
2019 18
2020 24
2021 18
2022 17
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Results by year
Filters applied: . Clear all
Page 1
Diabetes and lipid metabolism.
Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A. Athyros VG, et al. Among authors: stavropoulos k. Hormones (Athens). 2018 Mar;17(1):61-67. doi: 10.1007/s42000-018-0014-8. Epub 2018 Apr 16. Hormones (Athens). 2018. PMID: 29858856 Review.
Hypertension in Metabolic Syndrome: Novel Insights.
Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Katsimardou A, et al. Among authors: stavropoulos k. Curr Hypertens Rev. 2020;16(1):12-18. doi: 10.2174/1573402115666190415161813. Curr Hypertens Rev. 2020. PMID: 30987573 Review.
Dysmetabolic Iron Overload in Metabolic Syndrome.
Sachinidis A, Doumas M, Imprialos K, Stavropoulos K, Katsimardou A, Athyros VG. Sachinidis A, et al. Among authors: stavropoulos k. Curr Pharm Des. 2020;26(10):1019-1024. doi: 10.2174/1381612826666200130090703. Curr Pharm Des. 2020. PMID: 32000639 Review.
Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy.
Imprialos KP, Stavropoulos K, Doumas M, Tziomalos K, Karagiannis A, Athyros VG. Imprialos KP, et al. Among authors: stavropoulos k. Curr Vasc Pharmacol. 2018 Jan 26;16(2):130-142. doi: 10.2174/1570161115666170609101502. Curr Vasc Pharmacol. 2018. PMID: 28595561 Review.
Pharmacological Management of Type 2 Diabetes Complications.
Doumas M, Imprialos K, Stavropoulos K, Athyros VG. Doumas M, et al. Among authors: stavropoulos k. Curr Vasc Pharmacol. 2020;18(2):101-103. doi: 10.2174/157016111802200101155519. Curr Vasc Pharmacol. 2020. PMID: 32013814 No abstract available.
Primary Aldosteronism: Novel Insights.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M. Stavropoulos K, et al. Curr Hypertens Rev. 2020;16(1):19-23. doi: 10.2174/1573402115666190415155512. Curr Hypertens Rev. 2020. PMID: 30987572 Review.
Hypertension in Pregnancy: Unanswered Questions.
Papademetriou V, Stavropoulos K, Patoulias D, Papadopoulos C, Georgios K, Toumpourleka M, Sachinidis A. Papademetriou V, et al. Among authors: stavropoulos k. Curr Pharm Des. 2021;27(36):3795-3803. doi: 10.2174/1381612827666210830091652. Curr Pharm Des. 2021. PMID: 34459373 Review.
Pharmacological Management of Diabetic Nephropathy.
Papademetriou V, Alataki S, Stavropoulos K, Papadopoulos C, Bakogiannis K, Tsioufis K. Papademetriou V, et al. Among authors: stavropoulos k. Curr Vasc Pharmacol. 2020;18(2):139-147. doi: 10.2174/1570161117666190405164749. Curr Vasc Pharmacol. 2020. PMID: 30961500 Review.
Impact of Primary Aldosteronism in Resistant Hypertension.
Stavropoulos K, Imprialos KP, Patoulias D, Katsimardou A, Doumas M. Stavropoulos K, et al. Curr Hypertens Rep. 2022 Aug;24(8):285-294. doi: 10.1007/s11906-022-01190-9. Epub 2022 Apr 21. Curr Hypertens Rep. 2022. PMID: 35445928 Review.
134 results